Home Remedies for Eczema and Psoriasis Relief
Click to expand
UP NEXT
There's a slim chance you've made it all the way to 2021 without hearing someone extol the benefits of cannabidiolCBD.
Fans claim it can do everything from relieve stress and anxiety to improve chronic pain, lessen depression, ease arthritis, and improve epilepsy.
Psoriasis relief may make the list of potential health benefits.
But can CBD oils or other products really provide much-needed itch and pain relief? Can it help clear up psoriasis plaques?
The short, and somewhat unsatisfying answer is maybe.
But more research is needed before any recommendations can be made, says Adam Friedman, MD, professor and chair of dermatology at George Washington School of Medicine and Health Sciences in Washington, D.C.
Affecting as many as eight million people in the United States, psoriasis is an inflammatory skin condition that occurs when your immune system cranks up the production of skin cells.
Instead of shedding, these cells build up on top of your skin, forming raised, reddened plaques covered with silvery scales. These plaques may itch or sting.
Psoriasis can show up anywhere on your body, but it is most commonly seen on the lower back, elbows, knees, legs, soles of the feet or palms, and scalp.
And it's more than just a skin condition and a nuisance.
About 30 percent of people with psoriasis also develop joint pain, inflammation, and limited mobility that are associated with psoriatic arthritis, according to the National Psoriasis Foundation. Your likelihood of developing psoriatic arthritis is even higher if you have scalp psoriasis.
What's more, the underlying inflammation of psoriasis is linked to a higher risk for heart disease and diabetes.
Psoriasis can also damage self-esteem and take a heavy toll on your quality of life if left untreated.
CBD comes from the Cannabis sativa plant.
Both marijuana and its cousin, hemp, are cannabis plants, and both contain CBD. But there's a big difference between the two.
Marijuana has a higher concentration of THC, or delta-9 tetrahydrocannabinol, which is the ingredient that gets you high.
Some CBD products can also get you high, they don't always. That depends on whether the product comes from hemp or marijuana and whether it contains enough THC. Check out more about CBD vs. THC.
CBD comes in a variety of forms, and products containing it seem to grow by the day. Generally speaking, you'll find CBD as the following products:
THC and CBD interact with endocannabinoid receptors throughout your body in specific tissues or the nervous system.
This interaction may result in reduced inflammation, itching, pain relief, better sleep, and decreased anxiety, explains Jason E. Hawkes, MD, an associate clinical professor of dermatology at UC Davis Health in Rocklin, California.
There aren't many high-quality studies looking at CBD in people with psoriasis or other skin conditions. The studies we do have were conducted in lab cells or animals. Those may be encouraging, but they're just a start.
As such, experts can't say with any degree of certainty that it can help.
There is reason for optimism, says Dr. Friedman.
"There's a lot of hype that is sadly built around limited evidence, but from a purely biological standpoint, it does make sense that CBD oil can improve psoriasis symptoms," he says.
Studies in skin cells have shown that endocannabinoids like CBD can inhibit the inflammation that initiates and precipitates a psoriasis flare, he says.
"Preclinical studies in cells or animals suggest that CBD can affect key immune pathways, such as T helper-17, which seems to be central to the inflammation of psoriasis," says Dr. Friedman.
One study of 20 people, including five who had psoriasis, found that applying a CBD-enriched ointment to the affected skin twice daily for three months significantly improved psoriasis symptoms.
What's more, there were no irritant or allergic reactions seen during the treatment period. The study appears in a 2019 issue of Clinical Therapeutics.
The big question is whether the CBD made any difference at all. It's possible the improvement came from the use of the ointment.
"Simply moisturizing your skin can soften the really thick layer of skin in psoriasis, and that alone can have some benefit," Dr. Friedman says.
CBD is often combined with other ingredients that target pain, irritation, or itching, like camphor. And it may have salicylic acid, which breaks down thick, scaly skin and could enhance the effects of a moisturizing agent.
"There is a decent amount of preclinical evidence that if we get CBD where it needs to be, it will work," Dr. Friedman says.
But that's easier said than done. One way to accomplish it is to shrink the CBD particles down to the nano level so they can more easily pass through the skin. A nanometer is one-billionth of a meter.
There are many other factors that would need to be studied, too. After all, researchers don't yet know whether a cream applied to the skin might help psoriasis more than a swallowed capsuleor if the CBD in gummies will have any effect at all.
Scientists need to study disease severity, strain-specific compounds, concentration and dosing, method of delivery, and treatment duration, says Dr. Hawkes.
"We need studies looking at dosage and CBD concentration as well as drug interaction and allergy or irritation concerns in ingredients," says Mark Moyad, MD, MPH, the Jenkins/Pokempner Director of Preventive & Alternative Medicine at the University of Michigan Medical Center in Ann Arbor.
Topical steroids are a common treatment for psoriasis.
"Steroids tell your immune cells to self-destruct, but cannabinoids like CBD aren't so focused on blocking or killing these cells," Dr. Friedman says.
Instead, CBD aims to resolve inflammation.
"In theory, CBD binds to receptors on immune cells and instructs these cells to stop secreting pro-inflammatory cytokines and start rebuilding," he explains.
While there are a number of highly effective and safe topical and systemic treatments for psoriasis, many people still live with chronic itching, pain, and the stigma and psychosocial consequences of having a highly visible skin condition, says Dr. Hawkes.
"It is, therefore, not surprising that patients affected with psoriatic disease have sought relief from their disease via a variety of adjunctive treatment options, including cannabis-based products like CBD," he says.
That said, he stresses that CBD should never be used in place of other psoriasis treatments recommended by your doctor. If you do use it, it's simply an add on to the rest of your therapy.
The CBD industry may be here to stay, but it wasn't always so booming. In the past few years, demand grew, and supply ballooned.
Credit goes to the 2018 Farm Bill, which removed hemp and its derivatives with low THC from the Controlled Substances Act (CSA), which is where THC currently remains.
That means farmers can legally cultivate hemp and companies can legally produce hemp productsincluding those with CBDas long as they contain no more than 0.3 percent THC.
It's always a good idea to see what's legal in your state. (The National Conference of State Legislatures keeps a running tally of where medical marijuana is legal.) Some states restrict buying hemp-based CBD products.
There's no shortage of places to buy CBD products, both online and in person.
But Dr. Friedman cautions that there's minimal oversight. And that means it's buyer beware.
"There is no way to tell for sure what you are getting," he says.
CBD products vary widely in their concentrations, with nearly half having lower concentrations of CBD than stated on the labels, according to research in a 2017 issue of JAMA.
And some over-the-counter CBD products have impurities that can cause allergic dermatitis, found a 2020 study in Clinical Toxicology.
If you're set on trying CBD, shop around before purchasing. There are steps you can take to make sure you get the safest and most accurate CBD product possible.
Your best bet is to go directly to a company website and ask for the certificate of analysis (COA). This document provides results of any and all testing of the supplements.
In states where marijuana is legal for medicinal or recreational purposes, the state health department may keep a list of reputable vendors.
State-licensed dispensaries may have higher-quality products than random over-the-counter brands because there is some oversight coming from the state's Department of Health, Dr. Friedman says.
"Look for transparent ingredient lists and a good brand reputation, and have open conversations with health care providers [to] best navigate this rapidly evolving cannabis landscape," Dr. Hawkes advises.
Some patient advocate associations for psoriasis may have helpful resources for you.
"For psoriasis patients specifically, I also recommend that they seek out additional resources from established medical organizations and patient advocacy groups that may help them make informed decisions, such as the National Psoriasis Foundation, which is currently working to put out psoriasis guidelines related to cannabis use in the setting of psoriatic disease," he adds.
The potential risks of CBD and other cannabis-derived products in people with psoriasis and other inflammatory skin diseases hasn't been carefully studied, Dr. Hawkes stresses.
"The small number of clinical studies that have been conducted for non-psoriasis conditions are informative and suggest that potential risks should be considered, especially in patients with psoriatic disease," he says.
For example, people with psoriasis are at increased risk for joint inflammation, heart disease, stroke, obesity, diabetes, liver disease, inflammatory bowel disease, sleep disorders, depression, and anxiety.
"In several studies, systemic CBD and other cannabis-derived products were associated with worsening cardiovascular disease, obesity, and diabetes, fatty liver disease, or higher likelihood of surgery for the treatment of inflammatory bowel disease," Dr. Hawkes says.
People with psoriasis need to be aware of the potential worsening of those underlying conditions with systemic cannabis products.
"Potential adverse events are also more likely with systemic or high-dose administration compared to other delivery methods, such as limited or topical applications of CBD oil," he says.
Considering the lack of evidence, is CBD worth a try if you have psoriasis?
"For psoriasis patients with specific complaints, such as pain, itching, or trouble sleeping, cannabis-derived products could help reduce the negative impact these symptoms have on their life," Dr. Hawkes says.
But if you're going to use CBD, choose a reputable brand and let your doctor know about anything that you are using to help with your psoriasis symptoms. And remember: never replace your tried-and-true psoriasis treatments with CBD.
Not ready to jump on the CBD bandwagon just yet? It's OK to wait it out. The medical community is taking notice of CBD, conducting more studies that aim to get to the bottom of its uses.
"As a medical community, we are going to have to think creatively about ways to evaluate and determine the safety and effectiveness of CBD products for specific medical conditions," Dr. Hawkes says.
And the clock is ticking. "We all have to advance our understanding of CBD and other cannabinoid derivates because the cannabis product industry is here to stay," he adds.
The post Does CBD Help Psoriasis? Heres What Experts Say appeared first on The Healthy.
Originally posted here:
Does CBD Help Psoriasis? Here's What Experts Say The Healthy - msnNOW
- Guselkumab Demonstrates Significant Improvement in Psoriasis Symptoms and HRQoL, Reduces Sexual Impairment ... - Dermatology Times - April 18th, 2024 [April 18th, 2024]
- Psoriasis Patients with Arthralgia At Increased Risk of Psoriatic Arthritis Development - MD Magazine - April 18th, 2024 [April 18th, 2024]
- Diagnosing Psoriatic Arthritis for the Dermatologist: Guidance From the Experts - Medscape - April 18th, 2024 [April 18th, 2024]
- Secukinumab 300 mg May Improve PsA or Active Psoriasis More Than 150 mg - MD Magazine - April 18th, 2024 [April 18th, 2024]
- The Impact of Pediatric Plaque Psoriasis on Children and Caregivers - HMP Global Learning Network - April 18th, 2024 [April 18th, 2024]
- Guselkumab Led to Improvements Over Several Psoriatic Arthritis Disease Domains - MD Magazine - April 18th, 2024 [April 18th, 2024]
- Dual Diagnosing and Managing Psoriasis and Psoriatic Arthritis - The Dermatologist - April 18th, 2024 [April 18th, 2024]
- Etanercept Effective for Psoriasis, Rheumatic Disease Among Patients Extending Treatment After 12-Weeks - MD Magazine - February 9th, 2024 [February 9th, 2024]
- High Response Rates in Psoriasis With Oral IL-23 Inhibitor - Medpage Today - February 9th, 2024 [February 9th, 2024]
- Psoriasis and eczema have complex causes and consequences that researchers are seeking to uncover - Medical Xpress - February 9th, 2024 [February 9th, 2024]
- New Hope in Treatment of Plaque Psoriasis: Study Shows Promising Results - Medriva - February 9th, 2024 [February 9th, 2024]
- No Difference in Psoriasis Immune Response Despite Switch Between AVT02, Adalimumab - MD Magazine - February 9th, 2024 [February 9th, 2024]
- Oral IL-23 Receptor Antagonist Peptide Effective in PASI Reduction for Psoriasis - MD Magazine - February 9th, 2024 [February 9th, 2024]
- Breakthrough in Psoriasis Treatment: JNJ-77242113 Shows Promising Results - Medriva - February 9th, 2024 [February 9th, 2024]
- Promising Results from Phase II Trial of Oral Interleukin Inhibitor for Psoriasis Treatment - Medriva - February 9th, 2024 [February 9th, 2024]
- Promising Results from the FRONTIER 1 Trial - An Exploration of JNJ-77242113 in the Treatment of Moderate-to ... - Medriva - February 9th, 2024 [February 9th, 2024]
- Personal Experience with Psoriatic Arthritis and Atopic Dermatitis - Medriva - February 9th, 2024 [February 9th, 2024]
- Rising Cost of Stelara: Impact on Patients and Johnson & Johnson's Market Performance - Medriva - February 9th, 2024 [February 9th, 2024]
- Global Psoriatic Arthritis (PsA) Treatment Market to achieve a remarkable US$ 15.6 Billion by 2028, - PharmiWeb.com - February 9th, 2024 [February 9th, 2024]
- Tremfya potential highlighted by industry analyst GlobalData - The Pharma Letter - May 31st, 2023 [May 31st, 2023]
- Stress Leads to Increased Risk of Depression, Anxiety for Psoriasis ... - MD Magazine - May 31st, 2023 [May 31st, 2023]
- Janssen Announces Positive Results From Guselkumab Psoriatic ... - Dermatology Times - May 31st, 2023 [May 31st, 2023]
- Early Intervention with Secukinumab May Be Effective for Patients ... - MD Magazine - May 31st, 2023 [May 31st, 2023]
- VEGF-A Inhibition Downregulates Blood Vessel Area in Psoriasis - Dermatology Times - May 31st, 2023 [May 31st, 2023]
- Scratching the itch, Lynk Pharmaceuticals trialling ointment for ... - OutSourcing-Pharma.com - May 31st, 2023 [May 31st, 2023]
- Brepocitinib More Efficacious Than Placebo in Long-Term Psoriatic ... - Dermatology Times - May 31st, 2023 [May 31st, 2023]
- For Patients With Birthmarks, Psychosocial Interventions Improved ... - Dermatology Times - May 31st, 2023 [May 31st, 2023]
- Robert Hariri, MD: Natural Killer Cell Therapy Shows Remarkable ... - MD Magazine - May 31st, 2023 [May 31st, 2023]
- Nalbuphine ER Tablets Show Promise as Cough Therapy in ... - MD Magazine - May 31st, 2023 [May 31st, 2023]
- Benefit of Empagliflozin in HFpEF Consistent Regardless of Diuretic ... - MD Magazine - May 31st, 2023 [May 31st, 2023]
- selectION reports results from SAD stage of si-544 Phase Ib trial - Clinical Trials Arena - May 31st, 2023 [May 31st, 2023]
- No Link Observed Between Gastrointestinal Tract Surgery and New ... - MD Magazine - May 30th, 2023 [May 30th, 2023]
- Lynk doses first cohort in Phase Ib trial of psoriasis therapy - Clinical Trials Arena - May 30th, 2023 [May 30th, 2023]
- Metabolic Inflammation Contributes to Depression in Psoriatic Disease - Dermatology Times - May 30th, 2023 [May 30th, 2023]
- Encouraging Diversity and Inclusion for Patients With Psoriatic ... - MD Magazine - May 30th, 2023 [May 30th, 2023]
- The Weekly Roundup: May 22-26 - Dermatology Times - May 30th, 2023 [May 30th, 2023]
- Pediatric Psoriasis Market: A Study of the Industry's Key Applications ... - The Navajo Post - May 30th, 2023 [May 30th, 2023]
- Phototherapy Lamps Market are set to witness a CAGR of 5.8 ... - Digital Journal - May 30th, 2023 [May 30th, 2023]
- Celltrion seeks approval for Stelara biosimilar in EU - The Investor - May 30th, 2023 [May 30th, 2023]
- Peter Marinkovich, MD: FDA Approval of B-VEC Gene Therapy for ... - MD Magazine - May 30th, 2023 [May 30th, 2023]
- Nick Stucky, MD, Phd: Implications for Media Influence on Minoxidil ... - MD Magazine - May 30th, 2023 [May 30th, 2023]
- Tildrakizumab Linked With HRQOL Improvement in Psoriasis in a Real-World Setting - AJMC.com Managed Markets Network - May 18th, 2023 [May 18th, 2023]
- Clinical Utility of Deucravacitinib for the Management of Moderate to ... - Dove Medical Press - May 18th, 2023 [May 18th, 2023]
- Covid-19 and Psoriasis: Is there a link? - Dunya News - May 18th, 2023 [May 18th, 2023]
- Improvement Needed in Study Interventions to Better Skin Self ... - AJMC.com Managed Markets Network - May 18th, 2023 [May 18th, 2023]
- Reviva Pharmaceuticals Announces Intent to File an IND for Brilaroxazine in Psoriasis After Promising Preclinical Data - Marketscreener.com - May 18th, 2023 [May 18th, 2023]
- Adam Friedman, MD: Addressing Disparities in Care for Patients ... - MD Magazine - May 18th, 2023 [May 18th, 2023]
- Early-Infancy Meningitis Infection Linked With Increased Risk of ... - AJMC.com Managed Markets Network - May 18th, 2023 [May 18th, 2023]
- NOVN: Counting Down to PDUFA - Yahoo Finance - May 18th, 2023 [May 18th, 2023]
- Psoriatic Arthritis (PsA) Treatment Market is likely to register CAGR ... - Future Market Insights - May 18th, 2023 [May 18th, 2023]
- New campaign raises awareness of topical steroid withdrawal - Professional Beauty - May 18th, 2023 [May 18th, 2023]
- MoonLake Immunotherapeutics completes patient enrollment and randomization ahead of schedule in a Phase 2 trial of the Nanobody sonelokimab in... - February 2nd, 2023 [February 2nd, 2023]
- EVELO BIOSCIENCES, INC. : Costs Associated with Exit or Disposal Activities, Change in Directors or Principal Officers, Other Events (form 8-K) -... - February 2nd, 2023 [February 2nd, 2023]
- 12 Ways to Treat Psoriasis at Home - Healthline - January 22nd, 2023 [January 22nd, 2023]
- DTC Advertising Of Prescription Drugs In The U.S. Often Promotes Products With Comparatively Low Therapeutic Value - Forbes - January 19th, 2023 [January 19th, 2023]
- Types of Psoriasis: Pictures, Symptoms and Treatments - Healthline - December 18th, 2022 [December 18th, 2022]
- Psoriasis Pathogenesis and Treatment - PMC - PubMed Central (PMC) - November 23rd, 2022 [November 23rd, 2022]
- Drug-Provoked Psoriasis: Is It Drug Induced or Drug Aggravated? - November 23rd, 2022 [November 23rd, 2022]
- Im a Dermatologist and These 7 Things Could Be Making Your Psoriasis Worse - Well+Good - October 19th, 2022 [October 19th, 2022]
- 'Worst time of the year for me to be covered in scabs': Amber Heard's Alleged Ex Cara Delevingne Revealed Her Psoriasis Struggle Made Kate Moss Scream... - October 19th, 2022 [October 19th, 2022]
- Psoriasis: What It Is, Symptoms, Causes, Types & Treatment - October 17th, 2022 [October 17th, 2022]
- What is psoriasis and which foods ease symptoms? - Evening Standard - October 17th, 2022 [October 17th, 2022]
- Chronic inflammatory diseases: what they are - Emergency Live International - October 17th, 2022 [October 17th, 2022]
- How remote care can deliver a step change in treatment for inflammatory skin conditions - PoliticsHome - October 17th, 2022 [October 17th, 2022]
- Probiotics Supplementation may Improve Symptoms of Hyperuricemia and Gout - Rheumatology Network - October 15th, 2022 [October 15th, 2022]
- Psoriasis Pathogenesis and Treatment - PubMed - October 2nd, 2022 [October 2nd, 2022]
- Best and Worst Drinks for Psoriasis - Everyday Health - October 2nd, 2022 [October 2nd, 2022]
- These Are the 10 Most Common Chronic Skin Conditionsand the Most Important Facts to Know About Them - Parade Magazine - October 2nd, 2022 [October 2nd, 2022]
- Survey Addresses Concerns Regarding Reproductive Healthcare Communication in Women with RA, PsA - Rheumatology Network - October 2nd, 2022 [October 2nd, 2022]
- Psoriasis Types, Symptoms & Causes | NIAMS - September 29th, 2022 [September 29th, 2022]
- What Is Psoriasis And Can It Be Treated? - Forbes - September 29th, 2022 [September 29th, 2022]
- Plaque Psoriasis Treated With Tildrakizumab Shown to be Effective in Real-World Settings - MD Magazine - September 29th, 2022 [September 29th, 2022]
- Alumis Announces Initiation of Patient Dosing in Phase 2 Clinical Trial of ESK-001 for the Treatment of Plaque Psoriasis - Business Wire - September 29th, 2022 [September 29th, 2022]
- 15 Items That Will Make Your Life With Psoriatic Arthritis Easier - BlackDoctor.Org - September 29th, 2022 [September 29th, 2022]
- Types of Psoriasis and Their Effects on the Immune System - Cureus - September 27th, 2022 [September 27th, 2022]
- MoonLake Immunotherapeutics to initiate global Phase 2 study of the Nanobody sonelokimab in patients with active psoriatic arthritis - BioSpace - September 27th, 2022 [September 27th, 2022]
- How diversity and inclusion continues to be incorporated in dermatology - PMLiVE - September 27th, 2022 [September 27th, 2022]
- Arcutis Announces Topline Results From ARRECTOR Pivotal Phase 3 Trial Of Roflumilast Foam 0.3% In Scalp A - Benzinga - September 27th, 2022 [September 27th, 2022]
- Psoriasis Treatment Market Size to Hit USD 51.24 Bn by 2030 - GlobeNewswire - August 15th, 2022 [August 15th, 2022]
- Ventyx Sees Initiation Of Mid-Stage Psoriasis Study In Q4 2022 Following Positive Data From Initial-Stage - Benzinga - August 15th, 2022 [August 15th, 2022]